ChemFeeds Site Navigation:
Journal Selection:
Search:

1) Predictive Biomarkers for IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


2) Targeting Wee-1 Kinase in mutp53 HNSCC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


3) BRG1 Bromodomain Radiosensitizes Tumor Cells (Molecular Cancer Therapeutics) Tuesday February 10th 2015


4) Metformin Inhibits Rac1 GTPase and Cancer Cell Migration (Molecular Cancer Therapeutics) Tuesday February 10th 2015


5) Role of TDP1 and TOP1 in Colorectal Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


6) GSK3{beta} Sustains Glioblastoma Invasion (Molecular Cancer Therapeutics) Tuesday February 10th 2015


7) CD147 Promotes Radioresistance in HCC Cells (Molecular Cancer Therapeutics) Tuesday February 10th 2015


8) Sequential Anti-EGFR Therapy in Lung Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


9) Onartuzumab and Erlotinib Inhibits EGFR-Mutated NSCLC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


10) Stromal HA Elevation Limits mAb-Mediated Cancer Therapy (Molecular Cancer Therapeutics) Tuesday February 10th 2015


11) Sunitinib Dose Escalation Overcomes Drug Resistance (Molecular Cancer Therapeutics) Tuesday February 10th 2015


12) Tumor-Suppressor Role of Notch3 in MTC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


13) Targeted Lung Cancer Therapy with SapC-DOPS (Molecular Cancer Therapeutics) Tuesday February 10th 2015


14) Identification of a Novel CXCR4 Antagonist for Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


15) Structure-Based Design of Novel Antiangiogenic Biologics (Molecular Cancer Therapeutics) Tuesday February 10th 2015


16) Pazopanib/Paclitaxel Combination in Advanced Solid Tumors (Molecular Cancer Therapeutics) Tuesday February 10th 2015


17) PDT Targeting Tumor-Associated Macrophages (Molecular Cancer Therapeutics) Tuesday February 10th 2015


18) ALA Derivatives in the Treatment of Cancer (Molecular Cancer Therapeutics) Tuesday February 10th 2015


19) PI3K/mTOR Inhibition Radiosensitizes NPC (Molecular Cancer Therapeutics) Tuesday February 10th 2015


20) Targeting Tumor-Propagating Cells in Human Glioblastoma (Molecular Cancer Therapeutics) Tuesday February 10th 2015


21) Preclinical Studies of Anti-Pancreatic Tumor Agent SKLB261 (Molecular Cancer Therapeutics) Tuesday February 10th 2015


22) Inhibition of mTORC1 and mTORC2 in Sarcoma (Molecular Cancer Therapeutics) Tuesday February 10th 2015


23) SAR125844, a Selective Intravenous MET Kinase Inhibitor (Molecular Cancer Therapeutics) Tuesday February 10th 2015


24) AMG 925 Overcomes FLT3 Inhibitor Resistance (Molecular Cancer Therapeutics) Tuesday February 10th 2015


25) Efficacy of AZD1480 against JAK-Mutated ALL (Molecular Cancer Therapeutics) Tuesday February 10th 2015


26) Berberine Induces Senescence of Glioma Cells (Molecular Cancer Therapeutics) Tuesday February 10th 2015


27) NK150460: A Potential Antitumor Drug Activating AhR (Molecular Cancer Therapeutics) Tuesday February 10th 2015


28) High-Throughput Drug Screening for Novel Radiosensitizers (Molecular Cancer Therapeutics) Tuesday February 10th 2015


29) Efficacy of TAK-733 in Melanoma (Molecular Cancer Therapeutics) Tuesday February 10th 2015


30) BAI1 and Nestin in Breast Cancer Brain Metastases (Molecular Cancer Therapeutics) Wednesday January 14th 2015


31) Kinase Inhibitor Responses in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


32) JAGGED2 Promotes Pancreatic Cancer Cell Migration (Molecular Cancer Therapeutics) Wednesday January 14th 2015


33) MET Amplification in Human and Murine Prostate Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


34) ANRIL Promotes Proliferation in NSCLC (Molecular Cancer Therapeutics) Wednesday January 14th 2015


35) Lack of NPP7 Enhances Colonic Tumorigenesis (Molecular Cancer Therapeutics) Wednesday January 14th 2015


36) LIM Kinases in Prostate Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


37) Human Nucleoside Transporter Inhibition by Kinase Inhibitors (Molecular Cancer Therapeutics) Wednesday January 14th 2015


38) {Delta}NP63{alpha}-Dependent CSC Behavior Is Regulated through CXCR4 (Molecular Cancer Therapeutics) Wednesday January 14th 2015


39) Inhibition of Neuroblastoma Development by Targeting Midkine (Molecular Cancer Therapeutics) Wednesday January 14th 2015


40) Arsenic Trioxide Directly Inhibits AMPK (Molecular Cancer Therapeutics) Wednesday January 14th 2015


41) Resistance to Cabazitaxel (Molecular Cancer Therapeutics) Wednesday January 14th 2015


42) SRT1720 Induces Lysosomal-Dependent Cell Death (Molecular Cancer Therapeutics) Wednesday January 14th 2015


43) Targeting CDKN1A/TP53 in Bladder Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


44) Preclinical Pharmacokinetics and Safety of Metuzumab (Molecular Cancer Therapeutics) Wednesday January 14th 2015


45) Diffusion of Bicyclic Peptides into Tumors (Molecular Cancer Therapeutics) Wednesday January 14th 2015


46) NIR-PIT for Disseminated Peritoneal Ovarian Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


47) Peptide-mAb Con{#x0237}ugate Crosses the Blood-Brain Barrier (Molecular Cancer Therapeutics) Wednesday January 14th 2015


48) iRGD Inhibits Metastasis and Repels Tumor Cells (Molecular Cancer Therapeutics) Wednesday January 14th 2015


49) Novel TMZ Analogues Overcome GBM Resistance (Molecular Cancer Therapeutics) Wednesday January 14th 2015


50) Combination of Axitinib and Crizotinib in Human Renal Cell Carcinoma (Molecular Cancer Therapeutics) Wednesday January 14th 2015


51) PP2A Inhibition Sensitizes Ovarian Cancer Cells to Cisplatin (Molecular Cancer Therapeutics) Wednesday January 14th 2015


52) YM155 Induces Apoptosis via DR5 in Pancreatic Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


53) Radioprotection of Brain Structure and Function by Porphyrin (Molecular Cancer Therapeutics) Wednesday January 14th 2015


54) Preclinical Evaluation of VT-464 in Prostate Cancer Models (Molecular Cancer Therapeutics) Wednesday January 14th 2015


55) AZD8186 Inhibits PI3K{beta}-Dependent Tumor Growth (Molecular Cancer Therapeutics) Wednesday January 14th 2015


56) MEK and PI3K Inhibition in Pancreatic Cancer (Molecular Cancer Therapeutics) Wednesday January 14th 2015


57) Preclinical Profile of Choline Kinase Alpha Inhibitors (Molecular Cancer Therapeutics) Wednesday January 14th 2015


58) Darinaparsin Kills Prostate Cancer Cells by Inhibiting Shh Signaling (Molecular Cancer Therapeutics) Wednesday January 14th 2015


59) Preclinical Characterization of HSP90{alpha}/{beta} Inhibitor TAS-116 (Molecular Cancer Therapeutics) Wednesday January 14th 2015


60) Repurposing Mebendazole as a Hedgehog Inhibitor (Molecular Cancer Therapeutics) Wednesday January 14th 2015


61) Acknowledgment to Reviewers (Molecular Cancer Therapeutics) Thursday December 4th 2014


62) Targeted Drug Discovery with TCGA, CMap, and CCLE (Molecular Cancer Therapeutics) Thursday December 4th 2014


63) Mouse Model of Human Lymphoma Therapy Heterogeneity (Molecular Cancer Therapeutics) Thursday December 4th 2014


64) BRAFV600E Blood Test (Molecular Cancer Therapeutics) Thursday December 4th 2014


65) Combinatorial Targeting of Notch1 and Ras/MAPK in Breast Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


66) miR-185 Is a Potential Target for TNBC Therapy (Molecular Cancer Therapeutics) Thursday December 4th 2014


67) Outcomes of Phase I Trials in Triple-Negative Breast Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


68) Role of miR24 in Nasopharyngeal Carcinoma (Molecular Cancer Therapeutics) Thursday December 4th 2014


69) miR141-CXCL1-CXCR2 Recruits Tregs in MPE (Molecular Cancer Therapeutics) Thursday December 4th 2014


70) miR200c Induces MDR and Metastasis (Molecular Cancer Therapeutics) Thursday December 4th 2014


71) Akt-Activated Endothelium and Bevacizumab in Ovarian Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


72) Doxycycline and Hepatocellular Carcinoma (Molecular Cancer Therapeutics) Thursday December 4th 2014


73) MEK1 Gene Mutation and Gastric Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


74) PTENP1 as ceRNA in ccRCC (Molecular Cancer Therapeutics) Thursday December 4th 2014


75) ADAM9 in Gastric Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


76) Cellular Role of A687V EZH2 in ALL (Molecular Cancer Therapeutics) Thursday December 4th 2014


77) RRAD Induces Temozolomide Resistance of Glioblastoma (Molecular Cancer Therapeutics) Thursday December 4th 2014


78) JAK1/STAT3 as a Therapeutic Target in Ovarian Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


79) Rapamycin Augments Antiglioma Immunotherapy (Molecular Cancer Therapeutics) Thursday December 4th 2014


80) CBS9106-Induced CRM1 Degradation Requires CRL Activity (Molecular Cancer Therapeutics) Thursday December 4th 2014


81) GEP Antibody and Chemosensitization (Molecular Cancer Therapeutics) Thursday December 4th 2014


82) ADC Targeting LIV-1 for Breast Cancer (Molecular Cancer Therapeutics) Thursday December 4th 2014


83) Tivantinib Overcomes Drug Resistance by ABC Transporter (Molecular Cancer Therapeutics) Thursday December 4th 2014


84) Selective Radioprotection of Normal Tissues (Molecular Cancer Therapeutics) Thursday December 4th 2014


85) Cannabinoid Activity in an Orthotopic Murine Glioma Model (Molecular Cancer Therapeutics) Thursday December 4th 2014


86) C. vasculum Compounds Possess Antitumor Potential (Molecular Cancer Therapeutics) Thursday December 4th 2014


87) Ashwagandha Inhibits Metastasis and Angiogenesis (Molecular Cancer Therapeutics) Thursday December 4th 2014


88) Novel Pan-ERBB Inhibitor for Treating Glioblastoma (Molecular Cancer Therapeutics) Thursday December 4th 2014


89) Alectinib Is a Potent Inhibitor of RET (Molecular Cancer Therapeutics) Thursday December 4th 2014


90) Cathepsin K Inhibitor for Metastatic Bone Disease (Molecular Cancer Therapeutics) Thursday December 4th 2014


91) Carfilzomib and Ricolinostat in NHL Cells (Molecular Cancer Therapeutics) Thursday December 4th 2014


92) In Vivo KRAS Silencing with siRNA (Molecular Cancer Therapeutics) Thursday December 4th 2014


93) Antitumor by Phage Protein-Targeting Micellar Paclitaxel (Molecular Cancer Therapeutics) Thursday December 4th 2014


94) PET Imaging of {beta}G Activity for Prodrug Therapy (Molecular Cancer Therapeutics) Thursday December 4th 2014


95) Combination Therapy for KIT-Mutant Mast Cells (Molecular Cancer Therapeutics) Thursday December 4th 2014


96) NT157 Suppresses IRS1/2 and Augments Prostate Cancer Therapeutic Response (Molecular Cancer Therapeutics) Thursday December 4th 2014


97) Targeting PCNA for Cancer Therapy (Molecular Cancer Therapeutics) Thursday December 4th 2014


98) Inhibition of MCT1 Potentiates Radiotherapy (Molecular Cancer Therapeutics) Thursday December 4th 2014


View: prev | next

#RealTimeChem:

Announcements:

Chem News Feed:

Catalytic C–H Activation of Indoles and Pyrroles

Experts question China's panda survey

So Long, Spock

AstraZeneca Will Spin Off Antibiotics

Making Alkyl Halides From Alcohols

BACTERIAL ROOTSThese branched twiglike structures are computer...

Bioinspired Antireflective Coating Could Help Devices Capture More Light

Distillations Podcast: Innovation & Obsolescence—The Life, Death, and Occasional Rebirth of Technologies

Gotta love George Whitesides

Obama Vetoes Keystone Pipeline

Friday Fun: WWWTP? Linkin Park Edition

PAINs And Good Old Med Chem

AZ Spins Off Anti-Infectives

Silent Spring master notes

NIH sets aside more than $40 million for study of human placenta


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()